| Circulating microbiome in blood of different circulatory compartments R Schierwagen, C Alvarez-Silva, MSA Madsen, CC Kolbe, C Meyer, ... Gut 68 (3), 578-580, 2019 | 133 | 2019 |
| Signalling via the osteopontin and high mobility group box-1 axis drives the fibrogenic response to liver injury E Arriazu, X Ge, TM Leung, F Magdaleno, A Lopategi, Y Lu, N Kitamura, ... Gut 66 (6), 1123-1137, 2017 | 120 | 2017 |
| High mobility group box‐1 drives fibrosis progression signaling via the receptor for advanced glycation end products in mice X Ge, E Arriazu, F Magdaleno, DJ Antoine, R dela Cruz, N Theise, N Nieto Hepatology 68 (6), 2380-2404, 2018 | 105 | 2018 |
| Rationale for the use of statins in liver disease R Schierwagen, FE Uschner, F Magdaleno, S Klein, J Trebicka American Journal of Physiology-Gastrointestinal and Liver Physiology 312 (5 …, 2017 | 65 | 2017 |
| Key events participating in the pathogenesis of alcoholic liver disease F Magdaleno, CC Blajszczak, N Nieto Biomolecules 7 (1), 9, 2017 | 62 | 2017 |
| Cartilage oligomeric matrix protein participates in the pathogenesis of liver fibrosis F Magdaleno, E Arriazu, MR de Galarreta, Y Chen, X Ge, LC de la Rosa, ... Journal of hepatology 65 (5), 963-971, 2016 | 62 | 2016 |
| Combination of CCl4 with alcoholic and metabolic injuries mimics human liver fibrosis MJ Brol, F Rösch, R Schierwagen, F Magdaleno, FE Uschner, ... American Journal of Physiology-Gastrointestinal and Liver Physiology 317 (2 …, 2019 | 48 | 2019 |
| Compartmentalization of immune response and microbial translocation in decompensated cirrhosis C Alvarez-Silva, R Schierwagen, A Pohlmann, F Magdaleno, FE Uschner, ... Frontiers in immunology 10, 69, 2019 | 42 | 2019 |
| Rho-kinase inhibitor coupled to peptide-modified albumin carrier reduces portal pressure and increases renal perfusion in cirrhotic rats S Klein, F Frohn, F Magdaleno, C Reker-Smit, R Schierwagen, ... Scientific reports 9 (1), 2256, 2019 | 33 | 2019 |
| The multikinase inhibitor regorafenib decreases angiogenesis and improves portal hypertension FE Uschner, F Schueller, I Nikolova, S Klein, R Schierwagen, ... Oncotarget 9 (90), 36220, 2018 | 29 | 2018 |
| Intestinal osteopontin protects from alcohol-induced liver injury by preserving the gut microbiome and the intestinal barrier function S Das, Z Song, H Han, X Ge, R Desert, D Athavale, SSB Komakula, ... Cellular and Molecular Gastroenterology and Hepatology 14 (4), 813-839, 2022 | 16 | 2022 |
| The specific NLRP3 antagonist IFM-514 decreases fibrosis and inflammation in experimental murine non-alcoholic steatohepatitis S Torres, MJ Brol, F Magdaleno, R Schierwagen, FE Uschner, S Klein, ... Frontiers in Molecular Biosciences 8, 715765, 2021 | 15 | 2021 |
| Aminoguanidine reduces diabetes‑associated cardiac fibrosis F Magdaleno, CC Blajszczak, CL Charles‑Niño, AM Guadrón‑Llanos, ... Experimental and Therapeutic Medicine 18 (4), 3125-3138, 2019 | 15 | 2019 |
| Osteopontin deletion drives hematopoietic stem cell mobilization to the liver and increases hepatic iron contributing to alcoholic liver disease F Magdaleno, X Ge, H Fey, Y Lu, H Gaskell, CC Blajszczak, C Aloman, ... Hepatology Communications 2 (1), 84-98, 2018 | 13 | 2018 |
| Combination of phosphodiesterase‐5‐inhibitors and beta blockers improves experimental portal hypertension and erectile dysfunction FE Uschner, K Glückert, R Paternostro, T Gnad, R Schierwagen, ... Liver international 40 (9), 2228-2241, 2020 | 11 | 2020 |
| TGR (mREN2) 27 rats develop non-alcoholic fatty liver disease-associated portal hypertension responsive to modulations of Janus-kinase 2 and Mas receptor S Klein, CE Kleine, A Pieper, M Granzow, S Gautsch, M Himmit, ... Scientific reports 9 (1), 11598, 2019 | 10 | 2019 |
| " Tipping" extracellular matrix remodeling towards regression of liver fibrosis: novel concepts. F Magdaleno, R Schierwagen, FE Uschner, J Trebicka Minerva Gastroenterologica e Dietologica 64 (1), 51-61, 2017 | 8 | 2017 |
| Selective LOXL2 inhibition: potent antifibrotic effects in ongoing fibrosis and fibrosis regression F Magdaleno, J Trebicka Gut 66 (9), 1540-1541, 2017 | 7 | 2017 |
| Neprilysin-dependent neuropeptide Y cleavage in the liver promotes fibrosis by blocking NPY-receptor 1 C Ortiz, S Klein, WH Reul, F Magdaleno, S Gröschl, P Dietrich, ... Cell Reports 42 (2), 2023 | 5 | 2023 |
| Udenafil decreases portal pressure and improves erectile dysfunction in liver cirrhosis FE Uschner, K Glückert, S Klein, F Magdaleno, R Schierwagen, ... Journal of Hepatology 68, S471, 2018 | 2 | 2018 |
Jonel TrebickaProfessor, University of MünsterVerified email at ukmuenster.de
